期刊文献+

合并儿茶酚胺心肌病患者嗜铬细胞瘤切除术麻醉处理1例 被引量:1

Anesthetic management of a patient undergoing pheochromocytoma resection complicated with catecholamine cardiomyopathy: a case report
原文传递
导出
摘要 患者,女性,年龄42岁,体重44.5 kg,因"发现血压升高1年余,心慌大汗2月余,咳嗽气紧1月余"入院。既往儿茶酚胺心肌病和高血压病史。入院检查,脑钠肽20560 pg/ml、血去甲肾上腺素37609 ng/L、血肾上腺素5687 ng/L。胸腹部CT:心脏体积增大,右侧肾上腺区肿块(4.0 cm×3.9 cm)。超声心动图:左心肥厚,室间隔及左心室后壁增厚(IVS 13 mm,LVPW 13 mm),主动脉瓣返流(中-重度),左室顺应性降低,舒张功能降低,EF 65%。术前诊断:(1)嗜铬细胞瘤;(2)急性左心衰竭;(3)儿茶酚胺心肌病;(4)高血压3级;(5)双肺肺炎。拟行机器人辅助腹腔镜下嗜铬细胞瘤切除术。手术当日左心衰竭症状已纠正,NYHA心功能分级Ⅱ或Ⅲ级,ASA分级Ⅲ级,肺部感染治愈,血压控制在120~135/65~85 mmHg(1 mmHg=0.133 kPa),心率控制在80~90次/min,近期补液量3500 ml/24 h。
作者 叶源才 许钊 梁鹏 Ye Yuancai;Xu Zhao;Liang Peng(Department of Anesthesiology,West China Hospital of Sichuan University,Chengdu 610041,China)
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2021年第3期371-372,共2页 Chinese Journal of Anesthesiology
  • 相关文献

参考文献1

二级参考文献67

  • 1Gijsenbergh F,Ramael S,Houwing N,et al.First human exposure of Org 25969,a novel agent to reverse the action of rocuronium bromide[J].Anesthesiology,2005,103(4):695-703.
  • 2de Boer HD,Driessen JJ,Marcus MA,et al.Reversal of rocuronium-induced(1.2 mg/kg)profound neuromuscular block by sugammadex:a multicenter,dose finding and safety study[J].Anesthesiology,2007,107(2):239-244.
  • 3Groudine SB,Soto R,Lien C,et al.A randomized,dose-finding,Phase II study of the selective relaxant binding drug,sugammadex,capable of safely reversing profound rocuronium-induced neuromuscular block[J].Anesth Analg,2007,104(3):555-562.
  • 4Sparr HJ,Vermeyen KM,Beaufort AM,et al.Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study:efficacy,safety,and pharmacokinetics[J].Anesthesiology,2007,106(5):935-943.
  • 5Vanacker BF,Vermeyen KM,Struys MM,et al.Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.Anesth[J].Analg,2007,104(3):563-568.
  • 6Puhringer FK,Rex C,Sielenkamper AW,et al.Reversal of profound,high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points:an international,multicenter,randomized,dose-finding safety assessor-blinded,Phase II trial[J].Anesthesiology,2008,109(2):188-197.
  • 7Rex C,Wagner S,Spies C,et al.Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia[J].Anesthesiology,2009,111(1):30-35.
  • 8Dahl V,Pendeville PE,Hollamann MW,et al.Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery[J].Eur J Anaesthesiol,2009,26(10):874-884.
  • 9Duvaldestin P,Kuizenga K,Saldien V,et al.A randomized,dose-response study of sugammadex given for the reversal of deep rocuronium-or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia[J].Anesth Analg,2010,110(1):74-82.
  • 10Fink H,Hollmann MW.Myths and facts in neuromuscular pharmacology.New developments in reversing neuromuscular blockade[J].Minerva Anestesiol,2012,78(4):473-482.

共引文献8

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部